Mustang Bio, Inc. Profile Avatar - Palmy Investing

Mustang Bio, Inc.

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene the…

Biotechnology
US, Worcester [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of MBIO's Analysis
CIK: 1680048 CUSIP: 62818Q104 ISIN: US62818Q2030 LEI: - UEI: -
Secondary Listings
MBIO has no secondary listings inside our databases.